Tenaya Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Tenaya Therapeutics Inc
TickerTNYA
CIK #0001858848
CUSIP87990A106
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address171 Oyster Point Blvd, Suite 500, South San Francisco, CA 94080
Source [EDGAR]
CIK Filing 2011 - 2024
[0001858848] 10-K
[0001858848] 10-Q
[0001858848] 3
[0001858848] 4
[0001858848] 8-K
[0001858848] SC 13D
[0001858848] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Column Group III LP Tenaya Therapeutics Inc [2022-12-01] 6.9
Price T Rowe Associates Inc /MD/ Tenaya Therapeutics Inc [2022-02-14] 7.2
Walton Thomas Layton Tenaya Therapeutics Inc [2022-02-14] 0.0
RTW Investments LP Tenaya Therapeutics Inc [2022-02-14] 6.0
Walton Thomas Layton Tenaya Therapeutics Inc [2022-02-14] 0.0
Ugwumba Chidozie Tenaya Therapeutics Inc [2022-02-14] 6.4
Column Group III LP Tenaya Therapeutics Inc [2022-02-11] 10.7
FMR LLC Tenaya Therapeutics Inc [2021-08-10] 0.0
Casdin Capital LLC Tenaya Therapeutics Inc [2021-08-09] 8.7
RA Capital Management LP Tenaya Therapeutics Inc [2021-08-09] 8.6
Walton Thomas Layton Tenaya Therapeutics Inc [2021-08-09] 6.76
Form 3/4/5 Filer 2011 - 2024
Burroughs Amy L.
Tenaya Therapeutics, Inc.
Williams R Sanders
Stehman-Breen Catherine
Chen Jin-Long
Goeddel David V
Lee June
Parschauer Karah Herdman
Srivastava Deepak
Walsh Jeffrey T.
Column Group III-A LP
TCG Opportunity III GP, LLC
Column Group III GP LP
Column Group Opportunity III GP, LP
Column Group III LP
Column Group Opportunity III, LP
Hoey Timothy
Ali Faraz
Patterson Leone D
Tingley Whittemore
Casdin Eli
Casdin Capital, LLC
Casdin Private Growth Equity Fund GP LLC
Casdin Partners Master Fund, L.P.
Casdin Private Growth Equity Fund, L.P.
Kang JeenJoo
Form 13F Holdings
Firm Period DFND Voting Shares
Column Group LLC [2023-03-31] SOLE 9,400,290.0 9,400,290.0
Casdin Capital LLC [2023-03-31] SOLE 6,078,860.0 6,078,860.0
RA Capital Management LP [2023-03-31] SOLE 0.0 6,067,483.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 695,417.0 4,347,591.0
FMR LLC [2023-03-31] DFND 3,758,924.0 3,760,296.0
BlackRock Inc. [2023-03-31] SOLE 2,733,837.0 2,785,487.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 1,833,156.0
T. Rowe Price Investment Management, Inc. [2023-03-31] SOLE 491,178.0 1,564,525.0
Citadel Advisors LLC [2023-03-31] DFND 1,128,680.0 1,128,680.0
Regents of the University of California [2023-03-31] SOLE 960,957.0 960,957.0
Alphabet Inc. [2023-03-31] DFND 0.0 915,705.0
Euclidean Capital LLC [2023-03-31] SOLE 915,705.0 915,705.0
Geode Capital Management LLC [2023-03-31] DFND 790,790.0 790,790.0
Harvard Management Co Inc [2023-03-31] SOLE 673,270.0 673,270.0
State Street Corp [2023-03-31] DFND 462,500.0 496,800.0
StepStone Group LP [2023-03-31] DFND 462,163.0 462,163.0
Northern Trust Corp [2023-03-31] DFND 2,693.0 347,944.0
Trustees of Columbia University in the City of New York [2023-03-31] SOLE 40,218.0 291,828.0
Renaissance Technologies LLC [2023-03-31] SOLE 74,000.0 264,900.0
Bridgeway Capital Management LLC [2023-03-31] SOLE 181,900.0 181,900.0
Millennium Management LLC [2023-03-31] SOLE 160,608.0 160,608.0
Bank of New York Mellon Corp [2023-03-31] DFND 111,658.0 127,940.0
Two Sigma Investments LP [2023-03-31] SOLE 118,723.0 118,723.0
TD Asset Management Inc [2023-03-31] SOLE 114,930.0 114,930.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 113,033.0 113,033.0
GSA Capital Partners LLP [2023-03-31] SOLE 88,168.0 88,168.0
Susquehanna International Group LLP [2023-03-31] DFND 60,653.0 81,953.0
Morgan Stanley [2023-03-31] DFND 66,201.0 80,419.0
Nuveen Asset Management LLC [2023-03-31] DFND 74,559.0 74,559.0
Bank of America Corp /DE/ [2023-03-31] DFND 4,591.0 70,108.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com